T11438 |
GNE-1858
|
2680616-96-8
|
98.70%
|
|
GNE-1858 is an ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor (IC50s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutan...
|
T6760 |
APS-2-79 hydrochloride
|
2002381-31-7
|
98.64%
|
|
APS-2-79 hydrochloride (APS-2-79 HCl) is a MAPK antagonist that modulating KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the co...
|
T3707 |
GNE-3511
|
1496581-76-0
|
98.64%
|
|
GNE-3511 is a potent and selective dual leucine zipper kinase inhibitors.
|
T5S1895 |
Norisoboldine
|
23599-69-1
|
98.64%
|
|
1. Norisoboldine ((+)-Laurelliptine) might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as we...
|
T4264 |
Takinib
|
1111556-37-6
|
98.47%
|
|
Takinib (EDHS-206) is a specific and effective TAK1 inhibitor(IC50= 9.5 nM).
|
T12237 |
NMS-P715
|
1202055-32-0
|
98.41%
|
|
NMS-P715 is a selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
|
T11961 |
MBM-55S
|
2083624-07-9
|
98.38%
|
|
MBM-55S is an effective inhibitor of Nek2 with an IC50 of 1 nM. MBM-55S indecus cell cycle arrest and apoptosis thereby inhibiting the proliferation of cancer ce...
|
T26193 |
SKLB-163
|
1255099-06-9
|
98.31%
|
|
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
|
T10865L |
Cot inhibitor-1 hydrochloride
|
T10865L
|
98.26%
|
|
Cot inhibitor-1 hydrochloride is an inhibitor of tumor progression loci-2 kinase (IC50 = 28 nM) and inhibits the production of TNF-α in human whole blood (IC50 =...
|
T9034 |
MK2-IN-3
|
724711-21-1
|
98.14%
|
|
MK2-IN-3 (MK2 Inhibitor III) is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be ...
|
T62209 |
HS-276
|
2767422-72-8
|
98.07%
|
|
HS-276 is a highly selective, orally active inhibitor of TAK1 (Ki: 2.5 nM). HS-276 significantly inhibits TAK1 (IC50: 8.25 nM), CLK2 (IC50: 29 nM), GCK (IC50: 22...
|
T8911 |
Methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate
|
517870-17-6
|
97.95%
|
|
methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate is a biochemical.
|
T5643 |
NG25
|
1315355-93-1
|
97.59%
|
|
NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
|
T60012 |
HS-243
|
848249-10-5
|
97.34%
|
|
HS-243 is an inhibitor of IRAK-4 and IRAK-1 with IC50s of 20 and 24 nM. HS-243 shows anti-inflammatory and anticancer activity.
|
T40350 |
HPK1-IN-4
|
2739844-28-9
|
97.2%
|
|
HPK1-IN-4 is an HPK1 (MAPK41) inhibitor with an IC 50 of 0.061 nM. HPK1-IN-4 is often used as a preclinical immunotherapy tool compound.
|
T3101 |
NQDI-1
|
175026-96-7
|
97.19%
|
|
NQDI-1 (NQDI 1) is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50/Ki: 3 μM/500 nM).
|
T9880 |
ZINC05007751
|
591239-68-8
|
97.12%
|
|
ZINC05007751 is an effective inhibitor of NIMA-related kinase NEK6 (IC50 = 3.4 μM). ZINC05007751 is very selective against NEK1 and NEK6 with no significant acti...
|
T63119 |
NF-κB/MAPK-IN-1
|
2413940-56-2
|
97.03%
|
|
NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition ...
|
T36680 |
SM1-71
|
2088179-99-9
|
96%
|
|
SM1-71 is a potent multi-targeted acrylamide-modified TAK1 inhibitor that inhibits MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3,...
|
TN4114 |
Gardenin A
|
21187-73-5
|
95.15%
|
|
Gardenin A shows neurotrophic effects via activating MAPK/ERK, PKC, and PKA. Gardenin A exhibits antidepressant, anticonvulsant and anxiolytic effects.
|